Altarac, David
15  Ergebnisse:
Personensuche X
?
2

Pathogen-Targeted Clinical Development to Address Unmet Med..:

Watkins, Richard R ; Du, Bin ; Isaacs, Robin.
Clinical Infectious Diseases.  76 (2023)  Supplement_2 - p. S210-S214 , 2023
 
?
3

85. Efficacy of Sulbactam-Durlobactam (SUL-DUR) Compared to..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B..
Open Forum Infectious Diseases.  10 (2023)  Supplement_2 - p. , 2023
 
?
4

732. Microbiologic and clinical outcome concordance in the ..:

Altarac, David ; Miller, Alita ; McLeod, Sarah...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
 
?
5

734. Efficacy of sulbactam-durlobactam (SUL-DUR) versus col..:

Miller, Alita ; McLeod, Sarah ; Shapiro, Adam B...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
 
?
6

225. Efficacy and safety of sulbactam-durlobactam are consi..:

Miller, Alita ; Shapiro, Adam B ; McLeod, Sarah...
Open Forum Infectious Diseases.  9 (2022)  Supplement_2 - p. , 2022
 
?
 
?
9

Tuberculosis Treatment Through Directly Observed Therapy in..:

Altarac, David ; Dansky, Steven F.
Journal of Public Health Management and Practice.  1 (1995)  4 - p. 40-47 , 1995
 
?
10

Tuberculosis Treatment Through Directly Observed Therapy in..:

Altarac, David ; Dansky, Steven F.
Journal of Public Health Management and Practice.  1 (1995)  4 - p. 40-47 , 1995
 
?
11

Tuberculosis Treatment Through Directly Observed Therapy in..:

Altarac, David ; Dansky, Steven F.
Journal of Public Health Management and Practice.  1 (1995)  4 - p. 40-47 , 1995
 
?
12

Hiv‐associated Hodgkin disease: A clinical study of 18 case..:

Gold, Jay E. ; Altarac, David ; Ree, H. J....
American Journal of Hematology.  36 (1991)  2 - p. 93-98 , 1991
 
?
 
?
 
1-15